Singapore markets open in 3 hours 29 minutes
  • Straits Times Index

    2,525.61
    -3.03 (-0.12%)
     
  • S&P 500

    3,435.56
    -7.56 (-0.22%)
     
  • Dow

    28,210.82
    -97.97 (-0.35%)
     
  • Nasdaq

    11,484.69
    -31.80 (-0.28%)
     
  • BTC-USD

    12,945.67
    +1,888.66 (+17.08%)
     
  • CMC Crypto 200

    258.77
    +13.88 (+5.67%)
     
  • FTSE 100

    5,776.50
    -112.72 (-1.91%)
     
  • Gold

    1,927.70
    +12.30 (+0.64%)
     
  • Crude Oil

    40.00
    -1.70 (-4.08%)
     
  • 10-Yr Bond

    0.8160
    +0.0190 (+2.38%)
     
  • Nikkei

    23,639.46
    +72.42 (+0.31%)
     
  • Hang Seng

    24,754.42
    +184.88 (+0.75%)
     
  • FTSE Bursa Malaysia

    1,492.40
    -18.57 (-1.23%)
     
  • Jakarta Composite Index

    5,096.45
    -3.39 (-0.07%)
     
  • PSE Index

    6,278.59
    +165.88 (+2.71%)
     

Spectra7 Announces Closing of Final Tranche of Private Placement

·5-min read

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES

(TSXV:SEV) Spectra7 Microsystems Inc. ("Spectra7" or the "Company"), a leading provider of high-performance analog semiconductor products for broadband connectivity markets, announces that it has closed the final tranche of its previously announced non-brokered private placement (the "Private Placement"). The second and final tranche of the Private Placement consisted of the issuance of 16,677,920 units (the "Units") at a price of $0.025 per Unit for gross proceeds of $416,948.

Spectra7 also announces that it has entered into an agreement pursuant to which the Company intends to issue 2,734,600 Units at a deemed price of $0.025 per Unit to settle in full $68,365 owing to an arm’s length party (the "Debt Settlement").

On completion of the Private Placement and Debt Settlement, the Company will have issued a total of 40,459,424 Units for gross proceeds of $1,011,486.

Each Unit consists of one common share in the capital of the Company (each, a "Common Share") and one-half of one common share purchase warrant (each whole warrant, a "Warrant") with each Warrant being exercisable into one Common Share at an exercise price of $0.05 for a period of five years from the date of issuance, subject to adjustment upon certain customary events. The expiry date of the Warrants can be accelerated by the Company at any time following the date that is 4 month and one day after the issuance of the Warrants and prior to the expiry date of the Warrants if the closing price of the Common Shares on the TSX Venture Exchange (the "Exchange") is greater than $0.08 for any 10 non-consecutive trading days.

The net proceeds from the second tranche of the Private Placement are intended to be used for working capital, research and development, and general corporate purposes.

An insider of the Company participated in the second tranche of the Private Placement for an aggregate amount of $85,631. Pursuant to Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions ("MI 61-101"), the Private Placement constitutes a "related party transaction" as insiders of the Company subscribed for Units. The Company is relying on exemptions from the formal valuation and minority approval requirements of MI 61-101. The Private Placement was approved by all of the independent directors of the Company.

The Company paid finder’s fees totaling $5,250 to arm’s length parties in connection with the second tranche of the Private Placement. All securities issued in the Private Placement and Debt Settlement are subject to statutory and Exchange hold periods until the date that is four months and one day from the date of issuance.

All dollar amounts in this news release are denominated in Canadian dollars unless otherwise indicated.

The closing of the Private Placement and the Debt Settlement are subject to the approval of the Exchange.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities in the United States nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "1933 Act"), or any state securities laws and may not be offered or sold in the United States unless registered under the 1933 Act and any applicable securities laws of any state of the United States or an applicable exemption from the registration requirements is available.

ABOUT SPECTRA7 MICROSYSTEMS INC.

Spectra7 Microsystems Inc. is a high performance analog semiconductor company delivering unprecedented bandwidth, speed and resolution to enable disruptive industrial design for leading electronics manufacturers in virtual reality, augmented reality, mixed reality, data centers and other connectivity markets. Spectra7 is based in San Jose, California with a design centers in Cork, Ireland and technical support location in Dongguan, China. For more information, please visit www.spectra7.com.

Neither the TSX Venture Exchange nor its regulation services provided (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY NOTES

Certain statements contained in this press release constitute "forward-looking statements". All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Private Placement and the Debt Settlement and the intended use of proceeds thereof, and the Company’s strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words "believe", "expect", "aim", "intend", "plan", "continue", "will", "may", "would", "anticipate", "estimate", "forecast", "predict", "project", "seek", "should" or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company's expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company's Annual Information Form for the year ended December 31, 2019. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200925005515/en/

Contacts

Spectra7 Microsystems Inc.
James Bergeron
Investor Relations
289-512-0541
ir@spectra7.com